Cox-2 Inhibition in Radiation-induced Oral Mucositis
Completed · Phase 2 · Has a placebo group
Conditions studied: Oral Mucositis
In brief
Oral mucositis refers to ulcerative lesions of the oral mucosa that occur due to radiation therapy given for treatment of head and neck cancer. These lesions are painful, compromise nutrition and quality of life and may necessitate interruptions in radiation therapy, thus adversely affecting cancer therapy outcomes. This study examined the use of an anti-inflammatory medicine to reduce pain and severity of oral mucositis.
Key facts
- Study ID
- NCT00698204
- Run by
- UConn Health
- People needed
- 43
- Starts
- 2003-07-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2014-06-05
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Connecticut Health Center — Farmington, Connecticut, United States
- Hartford Hospital — Hartford, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.